Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Focan

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|July 24, 2010
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancerH Wildiers, C Fontaine, P Vuylsteke, et al.
Revue Medicale De Liege|March 1, 1990
[Intra-arterial and intravenous chemotherapy in the treatment of hepatic metastases of colorectal origin: review of the literature and preliminary results]V Mazy, C Focan, B Dallemagne, et al.
Revue Medicale De Liege|February 15, 1987
[Treatment of breast cancer. Our stance in 1986]J Bradfer, J Bury, J Closon, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Circadian CEA variability: when to sampleC Focan, D Focan-Henrard, M H Frere, et al.
Revue Medicale De Liege|April 26, 2013
[A trans-hospital pilot programme for onco-geriatry. The experience of the CHC-Liege]C Focan, E Warzee, G Demolin, et al.
Anticancer Research|May 4, 2005
Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trialC Focan, M P Graas, M Beauduin, et al.
Cancer|June 22, 1999
A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer ChronotherapyF Lévi, R Zidani, S Brienza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trialC Focan, J M Andrien, M T Closon, et al.
Pathologie-Biologie|June 9, 2005
[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study]C Focan, F Kreutz, L Longrée, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|July 24, 2010
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancerH Wildiers, C Fontaine, P Vuylsteke, et al.
Revue Medicale De Liege|March 1, 1990
[Intra-arterial and intravenous chemotherapy in the treatment of hepatic metastases of colorectal origin: review of the literature and preliminary results]V Mazy, C Focan, B Dallemagne, et al.
Revue Medicale De Liege|February 15, 1987
[Treatment of breast cancer. Our stance in 1986]J Bradfer, J Bury, J Closon, et al.
Journal of the National Cancer Institute|November 2, 1994
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trialF A Lévi, R Zidani, J M Vannetzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Circadian CEA variability: when to sampleC Focan, D Focan-Henrard, M H Frere, et al.
Revue Medicale De Liege|April 26, 2013
[A trans-hospital pilot programme for onco-geriatry. The experience of the CHC-Liege]C Focan, E Warzee, G Demolin, et al.
Anticancer Research|May 4, 2005
Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trialC Focan, M P Graas, M Beauduin, et al.
Cancer|June 22, 1999
A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer ChronotherapyF Lévi, R Zidani, S Brienza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trialC Focan, J M Andrien, M T Closon, et al.
Pathologie-Biologie|June 9, 2005
[Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study]C Focan, F Kreutz, L Longrée, et al.
Pageof 15